The First Sleep Apnea Drug Is Here
The weight-loss drug Zepbound (tirzepatide) now has one other main profit: on Dec. 20, it grew to become the primary drug accepted by the U.S. Food and Drug Administration (FDA) to deal with obstructive sleep apnea. In the trial that Lilly, the drug’s producer, submitted in April to the FDA, scientists reported that the drug […] More